Hawkins Parnell & Young's national litigation team is helping businesses across the United States navigate unprecedented legal challenges arising from the COVID-19 pandemic. Virtually every industry and job function has been impacted by the novel coronavirus outbreak. Many businesses will collapse from a myriad of litigation, investigatory, and regulatory costs – while others will thrive.
Hawkins Parnell’s COVID-19 Task Force is assisting clients with the significant risks and opportunities stemming from COVID-19. We are providing the latest insights and resources to guide our clients through this dynamic and constantly evolving situation. With a deep bench of first-chair trial lawyers and defense strategists, Hawkins Parnell’s 135-lawyer litigation team is working together to ensure each of our clients is afforded the firm’s collective knowledge and expertise on COVID-19 across a broad range of legal fields and industries.
Although trial success in high-stakes and bet-the-company litigation has always been the hallmark of Hawkins Parnell, our attorneys combine their unparalleled courtroom experience with their deep industry knowledge to manage litigation as regional and national counsel. Because of the depth of our expertise and experience handling complex medical, scientific, and technical issues, clients have also called upon us to globally manage the liability and/or medical aspects of litigation. We are known for employing many different techniques to present a client’s unique defense in litigation. Hawkins Parnell’s innovative attorneys have been involved in developing several of the major defense themes used across the country to showcase a defendant’s unique story in the context of traditional exposure and proximate cause defenses. Our experience has prepared us to help clients cope with the most challenging COVID-19 issues.
Many businesses are facing an onslaught of COVID-19 lawsuits from employees, customers, and shareholders. We are already seeing the potential abuses of this litigation. As experienced trial and national counsel to dozens of corporate defendants, Hawkins Parnell has developed an industry-leading model to manage and defend litigation on a local, national, or global scale. We develop corporate stories and strategic defenses for corporations in single and multi-jurisdictional litigation. With Hawkins Parnell at the helm, clients can maintain consistent business practices, proactively address emerging issues, and navigate the challenging course of litigation.
- July 2, 2020 – Event Cancellation Due to COVID-19
- July 1, 2020 – Model Policy Provides Tort Immunity for Businesses Operating During a Declared Public Emergency
- June 22, 2020 – Will COVID-19 Spur the Use of Arbitration Clauses in ERISA Plans?
- June 18, 2020 – Main Street Lending Program Update
- June 16, 2020 – COVID-19: Is an ESOP Still a Viable Exit Strategy in These Uncertain Times?
- June 11, 2020 – Negligent Failure to Warn Claims Against Retailers Shipping Products During COVID-19
- June 10, 2020 – Can My Company Require Antibody Testing and Should It?
- June 10, 2020 – The Risks of Reduction: Employee Furloughs
- June 10, 2020 – Developing COVID-19 on the Job and Employees’ Rights
- June 9, 2020 – COVID-19 Fallout: The Pandemic’s Effects on Consumer Class Action Litigation Against Financial Institutions and Debt Collectors
- June 9, 2020 – COVID-19 Paycheck Protection Program for Small Businesses
- June 9, 2020 – New Jersey Business Owner Liability in the Age of COVID-19
- June 1, 2020 – How Diverse Perspectives Can Further Business Goals During a Pandemic
- June 1, 2020 – Class Action Lawsuits: The New Legal Landscape in the Wake of COVID-19
- May 29, 2020 – Price Gouging During the COVID-19 Pandemic Leads to Civil and Criminal Actions
- May 28, 2020 – PPE Training and COVID-19: What Employers Need to Know
- May 27, 2020 – A Win for Debt Collectors: Massachusetts District Court Strikes Down COVID-19 Debt Collection Ban
- May 26, 2020 – Implementing a Reduction in Force During a Pandemic
- May 26, 2020 – The Disparate Impact of COVID-19 and its Effect on Litigation
- May 19, 2020 – Does No Exclusion Equal No Coverage? Bad Faith and Breach of Contract in the Time of COVID-19
- May 18, 2020 – Legal Malpractice Issues in the Time of COVID-19
- May 15, 2020 – Protecting Your Hotel From Liability During COVID-19
- May 14, 2020 – What Relief is Available Under Georgia Law When Performance of a Contract is Impacted by the COVID-19 Pandemic?
- May 13, 2020 – COVID-19 Insurance Coverage
- May 12, 2020 – COVID-19 and Long-term Care Facilities in Georgia
- May 12, 2020 – High Level Overview of Best Practices for Returning Employees to Work During the Midst of the COVID-19 Pandemic
- May 11, 2020 – The Effectiveness (or not) of Liability Waivers for Businesses Reopening in the COVID-19 Era
- May 11, 2020 – COVID-19 and Creditors’ Rights: The Effects of the Pandemic on Private Debt Collection
- May 8, 2020 – Movie Theater Patrons and the Novel Coronavirus
- May 8, 2020 – Product Liability for Fabric Mask Manufacturers During COVID-19
- May 6, 2020 – Attorney Wellness in the Time of COVID-19
- May 4, 2020 – Fed Updates Main Street Lending Program for Businesses
- May 4, 2020 – What Constitutes “Reasonable Care” by Premise and Business Owners in Light of the Coronavirus Pandemic?
- May 4, 2020 – Limiting Liability Exposure from COVID-19: Best Practices for an Essential Business to Protect Its Customers, Employees and Independent Contractors
- May 1, 2020 – COVID-19 Potential Claims for Retail and Hospitality Industries
- May 1, 2020 – Lead Risks Upon Buildings Reopening from COVID-19 Closures & Initial Litigation Inquiries for Lawsuits Based on Such Exposures
- May 1, 2020 – Grocery Stores and COVID-19: How to Distance Your Business From Liability
- April 30, 2020 – Navigating Insurance and Liability Issues as a Restaurateur in the Time of COVID-19
- March 26, 2020 – COVID-19 Tax and Other Business Relief and Shelter Orders
- March 23, 2020 – COVID-19 and Force Majeure Clauses
- March 20, 2020 – What Employers Need to Know Now About the Families First Coronavirus Response Act